Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reali Tide Biological Technology is a cGMP-certified biopharmaceutical manufacturer specializing in the research, development, and commercial production of peptide and polysaccharide active pharmaceutical ingredients (APIs). The company provides comprehensive CDMO and CMO services, supporting the pharmaceutical industry with high-quality intermediates and finished products for metabolic diseases, oncology, and medical aesthetics. Its product portfolio includes prominent GLP-1 and GIP receptor agonists such as semaglutide and tirzepatide, as well as specialty peptides like leuprorelin and elcatonin. Reali Tide leverages advanced peptide synthesis platforms and transdermal delivery technologies to serve global markets in the healthcare and personal care sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reali Tide Biological Technology.